Duchenne Research Fund
  • Home
  • Duchenne facts
  • Our story
  • Our projects
  • News
  • Get involved
    • Get involved
    • London Marathon
    • Y3P
    • Gallery
  • Contact
  • Donate
Select Page

Vamorolone shows improvements in strength and endurance in boys with Duchenne

26 Jun 2018

We are pleased to share an update from ReveraGen about its Vamorolone clinical trial. Vamorolone is an alternative treatment to existing steroids that aims to maximise the benefits while reducing the side effects. In 2014, The Duchenne Research Fund helped fund the...

Most recent:

  • DRF grants £40,000 to DMD Care UK project
  • Run the London Marathon with DRF
  • ReveraGen receives $3.3m NIH grant for Vamorolone
  • Solid announces collaboration with Ultragenyx
  • Two-year Vamorolone study completed

More about our projects:

administrative post award clinical post complementary current drug development early stage facility gene therapy past post project research standards of care

Jump to:

  • Donate
  • Contact Us
  • Get involved
  • Gallery
  • Our projects
  • Our story
  • Privacy
  • Home
  • Donate
  • Contact Us
  • Get involved
  • Gallery
  • Our projects
  • Our story
  • Privacy
  • Home
  • Facebook
  • Twitter
Copyright © 2020 The Duchenne Research Fund. Registered Charity No. 1119068. Designed and created by Sheli Rodney